Back to Journals » OncoTargets and Therapy » Volume 12

Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer

Total article views   HTML views PDF downloads Totals
7,281 Dovepress* 6,050+ 1,282 7,332
PubMed Central* 1,231 289 1,520
Totals 7,281 1,571 8,852
*Since 14 August 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar